---
$id: https://graph.org.ai/products/commodity/51323101
$type: Product
source: UNSPSC
code: "51323101"
title: "Anisacril"
class: "51323100"
classTitle: "Antihyperlipidemics and hypocholesterolemics, synthesized"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Anisacril

**UNSPSC Code**: 51323101
**Class**: [Antihyperlipidemics and hypocholesterolemics, synthesized](Antihyperlipidemics and hypocholesterolemics, synthesized.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-lipidemic agent and anorexiant with the molecular formula C22H18O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5TB1FV429Z, chemically known as 2-propenoic acid, 3,3-diphenyl-2-(o-methoxyphenyl)- but generally known as anisacril, which bears US NIH Compound Identifier 21203. European Medicines Agency schedules Anisacril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05519MIG. The term ANISACRIL is an International Non-Proprietary Name. ANISACRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, ANISACRIL remains the US FDA Preferred Term for this commodity. Anisacril bears US NLM identifiers UMLS ID C2983983 and NCI Concept Code C91010. SMILES: O(c1c(/C(=C(/c2ccccc2)c2ccccc2)C(=O)O)cccc1)C.

